DE1801303A1 - Chemische Verfahren und Produkte - Google Patents

Chemische Verfahren und Produkte

Info

Publication number
DE1801303A1
DE1801303A1 DE19681801303 DE1801303A DE1801303A1 DE 1801303 A1 DE1801303 A1 DE 1801303A1 DE 19681801303 DE19681801303 DE 19681801303 DE 1801303 A DE1801303 A DE 1801303A DE 1801303 A1 DE1801303 A1 DE 1801303A1
Authority
DE
Germany
Prior art keywords
heteroatoms
hydrogen
ring structure
hydroxy
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19681801303
Other languages
German (de)
English (en)
Inventor
Sarett Lewis Hastings
Ruyle William Vance
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE1801303A1 publication Critical patent/DE1801303A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE19681801303 1967-10-06 1968-10-04 Chemische Verfahren und Produkte Pending DE1801303A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67327367A 1967-10-06 1967-10-06

Publications (1)

Publication Number Publication Date
DE1801303A1 true DE1801303A1 (de) 1969-06-19

Family

ID=24701969

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19681801303 Pending DE1801303A1 (de) 1967-10-06 1968-10-04 Chemische Verfahren und Produkte

Country Status (7)

Country Link
US (1) US3558641A (enExample)
BR (1) BR6802728D0 (enExample)
CH (1) CH502981A (enExample)
DE (1) DE1801303A1 (enExample)
FR (1) FR1585315A (enExample)
GB (1) GB1214079A (enExample)
NL (1) NL161759C (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3676451A (en) * 1970-06-09 1972-07-11 Merck & Co Inc Thiazolylsalicylic acids

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3993763A (en) * 1969-03-18 1976-11-23 Ciba-Geigy Corporation Tertiary aminoacids as anti-inflammatory agents
US4001420A (en) * 1968-12-12 1977-01-04 Science Union Et Cie, Societe Francaise De Recherche Medical Thiazolyl benzoic acid compounds
US3682968A (en) * 1969-06-25 1972-08-08 Merck & Co Inc Anti-inflammatory salicylic acid derivatives
GB1308028A (en) * 1970-06-12 1973-02-21 Science Union & Cie Thiazolylbenzoic acid derivatives and a process for their manufactur
US3687971A (en) * 1970-06-22 1972-08-29 Merck & Co Inc 4-(pyrrolyl)-salicylic acid derivatives
US3929833A (en) * 1970-10-30 1975-12-30 Sandoz Ag Organic compounds
FR2128285A1 (en) * 1971-03-11 1972-10-20 Berlin Chemie Veb Imidazole derivs - with hypotensive mao-inhibitory, anticonvulsant antiinflammatory choleretic and antiviral activity prepn
FR2128292A1 (en) * 1971-03-12 1972-10-20 Berlin Chemie Veb Imidazole derivs - with hypotensive, mao-inhibitory, anticonvulsant antiinflammatory, choleretic and antiviral activity prepn
US3860640A (en) * 1972-04-12 1975-01-14 Nippon Shinyaku Co Ltd 3-alkoxy-5-substituted phenylacetic acids
US3865839A (en) * 1973-03-01 1975-02-11 Hoechst Co American Thiopyranopyrrolylsalicyclic acids and derivatives thereof
US4111935A (en) * 1975-01-02 1978-09-05 Smith Kline & French Laboratories Limited 3-chloro-6-phenylpyridazine compounds
US4152341A (en) * 1975-12-29 1979-05-01 Imperial Chemical Industries Limited Triaryl or diarylpyridyl methanes
GB1560880A (en) * 1975-12-29 1980-02-13 Ici Ltd Diphenylmethane derivatives and pharmaceutical compositions containing them
DE2818765A1 (de) * 1978-04-28 1979-11-08 Basf Ag Aminoderivate des 2-methyl-5-(2-hydroxystyrol)-1,3,4-thiadiazols
EP0195582B1 (en) * 1985-03-14 1990-01-24 SMITH KLINE DAUELSBERG GmbH 5-aminosalicylic acid derivatives of non-steroidal antiinflammatory acids
GB9204808D0 (en) * 1992-03-04 1992-04-15 Rhone Poulenc Rorer Ltd Novel compositions of matter
ES2639863B1 (es) * 2017-03-10 2018-09-20 Universidad De Granada Compuestos para el tratamiento de enfermedades causadas por la acumulación de oxalato

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3676451A (en) * 1970-06-09 1972-07-11 Merck & Co Inc Thiazolylsalicylic acids

Also Published As

Publication number Publication date
NL161759C (nl) 1980-03-17
US3558641A (en) 1971-01-26
GB1214079A (en) 1970-12-02
NL161759B (nl) 1979-10-15
NL6813639A (enExample) 1969-04-09
BR6802728D0 (pt) 1973-05-10
CH502981A (de) 1971-02-15
FR1585315A (enExample) 1970-01-16

Similar Documents

Publication Publication Date Title
DE1801303A1 (de) Chemische Verfahren und Produkte
DE2341753C2 (de) α-(3-tert.Butylamino-α-hydroxy-propylthio)- Thiazolderivate, Verfahren zu deren Herstellung und dieselben enthaltende pharmazeutische Zubereitung
DE3008056C2 (enExample)
DE2065636C3 (de) Tricyclische Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2432410C2 (de) 2-[4-(Imidazo[1,2a][pyridin-2-yl)-phenyl]-propionsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2658267A1 (de) Pyrimid-4-on- und -thion-derivate, ihre salze mit saeuren, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE1620458B2 (de) 2-anilino-nicotinsaeureverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DD149217A5 (de) Verfahren zur herstellung von pyrimidonderivaten
DD202291A5 (de) Verfahren zur herstellung von als histamin-h tief 1-rezeptor-antagonisten wirkenden pyrimidon-derivaten
DE2828091A1 (de) 4-substituierte thiazoloxamsaeuren sowie ihre salze und ester
DE3035086A1 (de) Cyclohexancarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende mittel
DE1620329B2 (de) 8-halogen-10-piperazino-10,11-dihydrobenzo (b,f) thiepinderivate und verfahren zu deren herstellung
DE2931418A1 (de) Neue imidazochinoxaline und deren salze, verfahren zu deren herstellung, deren verwendung als arzneimittel und die sie enthaltenden pharmazeutischen zusammensetzungen
DE2130709A1 (de) 4-Heterocyclische Salicylsaeuren und deren Derivate
CH621116A5 (enExample)
DE2128375C3 (de) Basische substituierte Alkylidenamino-oxyalkyl-carbonsäureester, deren Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate
DE2264657C2 (de) 5-Phenoxy-2-(1H)pyrimidinone, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE1960910A1 (de) Neue Benzylidenamino-oxyalkylcarbonsaeuren und Carbonsaeurederivate
DD154816B3 (de) Verfahren zur herstellung neuer pyridine
DE3883164T2 (de) Rhodanin-Derivate, Verfahren zu ihrer Herstellung, ihre Anwendung und pharmazeutische Zusammensetzungen, die sie enthalten.
DD209194A5 (de) Verfahren zur herstellung von als histamin h tief 2-rezeptor-antagonisten wirkenden pyrimidon-derivaten
DE2140865A1 (de) 1-imidazolyl-methanphosphonsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2406198A1 (de) Verfahren zur herstellung von neuen 2-amino-6-dialkylaminodihydropyridinen und ihre verwendung als arzneimittel
DE2641129A1 (de) Derivate des 5-aminomethylthiazols, ihr herstellungsverfahren und pharmazeutische zusammensetzungen
DE2725932A1 (de) Substituierte 2-vinylchromone und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
SH Request for examination between 03.10.1968 and 22.04.1971